Economics in vaccine expert reviews

<strong>Volume 28, Issue 16, Pages 2799-2916 (1 April 2010)</strong>

<strong>Regular Papers</strong>
<strong>A comparison of the use of economics in vaccine expert reviews</strong>
Pages 2841-2845
Philip Jacobs, Arto Ohinmaa

We reviewed how health economics has been included in the vaccine expert review processes in a sample of countries. We identified two kinds of review processes ā€“ those in which vaccines and drugs are assessed using a common process, and those in which vaccines are assessed within the infectious disease framework. In either process, the countries recommend that their national pharmaco-economic (i.e., guidelines developed for drugs) guidelines be used to conduct the studies, although the guidelines themselves differ between countries. As a result of these factors, the decision process and the study outcomes can differ between countries, but because the vaccine adoption process includes other criteria as well, economic factors will not necessarily alter the outcome.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.